Thalassemia
Thalassemia is a genetic blood disorder characterized by the abnormal production of hemoglobin, leading to anemia and other health complications. It results from mutations in the genes responsible for hemoglobin production, causing red blood cells to break down prematurely. Symptoms can range from mild to severe, including fatigue, weakness, and pale skin. Management of thalassemia often involves regular blood transfusions and iron chelation therapy to remove excess iron from the body. Advances in gene therapy and other treatments are being explored to improve the quality of life for those affected by thalassemia.
Related Conference of Thalassemia
Thalassemia Conference Speakers
Recommended Sessions
- Blood Disorders Diagnosis & Treatment
- Blood Transfusion
- Case reports of Hematology
- CellTherapy
- COVID-19 and Hematology
- Disorders of Vascular Bleeding
- Hematology
- Hematology Oncology
- Immunohematology
- Leukaemia and Lymphoma
- Multiple Myeloma, Amyloidosis, and Stem Cell Transplantation
- New Drug Development in Hematology
- Patient Blood Management
- Pediatric Hematology
- Stem Cell Research
- Thalassemia
- Therapeutic Apheresis
- Thrombosis and Coagulation
- Transfusion Medicine
- Transfusion Transmissible Infections
Related Journals
Are you interested in
- Advances in Hematologic Malignancies - Blood Disorders 2025 (Italy)
- Advances in Hemostasis and Thrombosis - Blood Disorders 2025 (Italy)
- Blood Disorders and the Immune System - Blood Disorders 2025 (Italy)
- Blood Disorders Diagnosis & Treatment - HEMATOLOGY 2025 (Spain)
- Blood Disorders in Aging Populations - Blood Disorders 2025 (Italy)
- Blood Transfusion - HEMATOLOGY 2025 (Spain)
- Case reports of Hematology - HEMATOLOGY 2025 (Spain)
- CellTherapy - HEMATOLOGY 2025 (Spain)
- COVID-19 and Hematology - HEMATOLOGY 2025 (Spain)
- Cutting-Edge Research in Blood Disorders - Blood Disorders 2025 (Italy)
- Disorders of Vascular Bleeding - HEMATOLOGY 2025 (Spain)
- Future Trends in Hematology: Artificial Intelligence and Big Data - Blood Disorders 2025 (Italy)
- Gene Therapy and Genetic Engineering in Hematology - Blood Disorders 2025 (Italy)
- Hematologic Toxicities and Side Effects of Cancer Therapy - Blood Disorders 2025 (Italy)
- Hematology - HEMATOLOGY 2025 (Spain)
- Hematology in Global Health: Addressing Disparities - Blood Disorders 2025 (Italy)
- Hematology Oncology - HEMATOLOGY 2025 (Spain)
- Immunohematology - HEMATOLOGY 2025 (Spain)
- Immunotherapy and Cellular Therapies in Hematology - Blood Disorders 2025 (Italy)
- Innovations in Red Blood Cell Disorders - Blood Disorders 2025 (Italy)
- Leukaemia and Lymphoma - HEMATOLOGY 2025 (Spain)
- Multiple Myeloma, Amyloidosis, and Stem Cell Transplantation - HEMATOLOGY 2025 (Spain)
- New Drug Development in Hematology - HEMATOLOGY 2025 (Spain)
- Novel Diagnostic Techniques and Biomarkers in Hematology - Blood Disorders 2025 (Italy)
- Patient Blood Management - HEMATOLOGY 2025 (Spain)
- Pediatric Hematology - HEMATOLOGY 2025 (Spain)
- Pediatric Hematology: Challenges and Innovations - Blood Disorders 2025 (Italy)
- Stem Cell Research - HEMATOLOGY 2025 (Spain)
- Stem Cell Transplantation and Regenerative Medicine - Blood Disorders 2025 (Italy)
- Thalassemia - HEMATOLOGY 2025 (Spain)
- Therapeutic Apheresis - HEMATOLOGY 2025 (Spain)
- Thrombosis and Coagulation - HEMATOLOGY 2025 (Spain)
- Transfusion Medicine - HEMATOLOGY 2025 (Spain)
- Transfusion Medicine: Advances and Challenge - Blood Disorders 2025 (Italy)
- Transfusion Transmissible Infections - HEMATOLOGY 2025 (Spain)